Search results
Results From The WOW.Com Content Network
Absorption may be slowed but not decreased when taken with food. Average peak concentration after administration of oral suspension is approximately 25–50% greater than the peak concentration following oral tablet or capsules administration. [11] Distribution It has high concentrations in bile and urine. It can cross the placenta and its ...
In rats, this dose was 1000 mg/kg/day, which is approximately 24 times a human dose of 200 mg twice daily based on mg/m 2 /day. In rabbits, the highest dose tested was 90 mg/kg/day, which is approximately four times a human dose of 200 mg twice daily based on mg/m 2 /day. This dose produced severe maternal toxicity and resulted in fetal ...
Common side effects of dolutegravir in clinical trials included insomnia and headache. Serious side effects included allergic reactions and abnormal liver function in patients who were also infected with hepatitis B or C. [15] The package insert warns against a mean rise in serum creatinine of 0.11 mg/dL due to inhibition of tubular secretion of creatinine and does not affect GFR.
Amisulpride is approved and used at low doses in the treatment of dysthymia and major depressive disorder. [10] [20] [11] [21] [22] [23] Whereas typical doses used in schizophrenia block postsynaptic dopamine D 2-like receptors and reduce dopaminergic neurotransmission, low doses of amisulpride preferentially block presynaptic dopamine D 2 and D 3 autoreceptors and thereby disinhibit dopamine ...
Mebeverine is an anticholinergic but its mechanism of action is not known; it appears to work directly on smooth muscle within the gastrointestinal tract and may have an anaesthetic effect, may affect calcium channels, and may affect muscarinic receptors.
The sodium salt faropenem sodium, available under the trade name Farom, has been marketed in Japan since 1997. ( CID 636379 from PubChem ) The prodrug form faropenem medoxomil [ 4 ] (also known as faropenem daloxate ) has been licensed from Daiichi Asubio Pharma by Replidyne , which plans to market it in conjunction with Forest Pharmaceuticals.
In at least one case, the patient had pre-existing low levels of methemoglobin reductase, [13] which likely predisposed her to the condition. It has also been reported to cause sulfhemoglobinemia. [4] [14] [15] [16] Phenazopyridine is an azo dye.
Saroglitazar is an insulin sensitizer.It is a first in class drug which acts as a dual PPAR agonist at the subtypes α (alpha) and γ (gamma) of the peroxisome proliferator-activated receptor (PPAR).